<--- Back to Details
First PageDocument Content
Neurological disorders / Syndromes / Antivirals / Rintatolimod / Hemispherx Biopharma / Chronic fatigue syndrome treatment / Chronic fatigue syndrome / Food and Drug Administration / Daniel Peterson / Health / Medicine / Pharmacology
Neurological disorders
Syndromes
Antivirals
Rintatolimod
Hemispherx Biopharma
Chronic fatigue syndrome treatment
Chronic fatigue syndrome
Food and Drug Administration
Daniel Peterson
Health
Medicine
Pharmacology

Microsoft Word - Summary Minutes AAC[removed]12_clean.doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 28,84 KB

Share Document on Facebook

Similar Documents

FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form reg

FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form reg

DocID: HI0B - View Document

Microsoft Word - Summary Minutes AAC[removed]12_clean.doc

Microsoft Word - Summary Minutes AAC[removed]12_clean.doc

DocID: BaWt - View Document

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

DocID: lQGP - View Document

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

FOOD AND DRUG ADMINISTRATION Center for Drug Evaluation and Research Arthritis Advisory Committee (AAC) Meeting FDA White Oak Campus, Building 31, The Great Room (Rm[removed]White Oak Conference Center, Silver Spring, Mar

DocID: lN3w - View Document

Microsoft Word - DRAFT Agenda AAC[removed]doc

Microsoft Word - DRAFT Agenda AAC[removed]doc

DocID: lARQ - View Document